Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Chris Vezina is active.

Publication


Featured researches published by Chris Vezina.


Journal of Biological Chemistry | 2008

Structural and functional characterization of disulfide isoforms of the human IgG2 subclass.

Thomas M. Dillon; Margaret Speed Ricci; Chris Vezina; Gregory C. Flynn; Yaoqing Diana Liu; Douglas S. Rehder; Matthew Plant; Brad Henkle; Yu Li; Songpon Deechongkit; Brian Varnum; Alain Balland; Pavel V. Bondarenko

In the accompanying report ( Wypych, J., Li, M., Guo, A., Zhang, Z., Martinez, T., Allen, M. J., Fodor, S., Kelner, D. N., Flynn, G. C., Liu, Y. D., Bondarenko, P. V., Ricci, M. S., Dillon, T. M., and Balland, A. (2008) J. Biol. Chem. 283, 16194-16205 ), we have identified that the human IgG2 subclass exists as an ensemble of distinct isoforms, designated IgG2-A, -B, and -A/B, which differ by the disulfide connectivity at the hinge region. In this report, we studied the structural and functional properties of the IgG2 disulfide isoforms and compared them to IgG1. Human monoclonal IgG1 and IgG2 antibodies were designed with identical antigen binding regions, specific to interleukin-1 cell surface receptor type 1. In vitro biological activity measurements showed an increased activity of the IgG1 relative to the IgG2 in blocking interleukin-1β ligand from binding to the receptor, suggesting that some of the IgG2 isoforms had lower activity. Under reduction-oxidation conditions, the IgG2 disulfide isoforms converted to IgG2-A when 1 m guanidine was used, whereas IgG2-B was enriched in the absence of guanidine. The relative potency of the antibodies in cell-based assays was: IgG1 > IgG2-A > IgG2 ≫ IgG2-B. This difference correlated with an increased hydrodynamic radius of IgG2-A relative to IgG2-B, as shown by biophysical characterization. The enrichment of disulfide isoforms and activity studies were extended to additional IgG2 monoclonal antibodies with various antigen targets. All IgG2 antibodies displayed the same disulfide conversion, but only a subset showed activity differences between IgG2-A and IgG2-B. Additionally, the distribution of isoforms was influenced by the light chain type, with IgG2λ composed mostly of IgG2-A. Based on crystal structure analysis, we propose that IgG2 disulfide exchange is caused by the close proximity of several cysteine residues at the hinge and the reactivity of tandem cysteines within the hinge. Furthermore, the IgG2 isoforms were shown to interconvert in whole blood or a “blood-like” environment, thereby suggesting that the in vivo activity of human IgG2 may be dependent on the distribution of isoforms.


Archive | 2003

Therapeutic Human Anti-IL-1R1 Monoclonal Antibody

Brian Varnum; Chris Vezina; Alison Witte; Francis H. Martin; Haichun Huang; Gary Elliott


Archive | 2001

Antibodies and other selective IL-1 binding agents that allow binding to IL-1 receptor but not activation thereof

Alison Witte; Brian Varnum; Chris Vezina


Archive | 2004

Screening method for antibodies and other selective IL-1 binding agents that allow binding to IL-1 receptor but not activation thereof

Alison Witte; Brian Varnum; Chris Vezina


Archive | 2008

Homogeneous antibody populations

Thomas M. Dillon; Pavel V. Bondarenko; Martin J. Allen; Alain Balland; Margaret Speed Ricci; Amy Guo; Wenyan Shen; Jeonghoon Sun; Chris Vezina


Journal of Theoretical Biology | 2007

Monotonicity of interleukin-1 receptor–ligand binding with respect to antagonist in the presence of decoy receptor

Gilles Gnacadja; Alex Shoshitaishvili; Michael J. Gresser; Brian Varnum; David J. Balaban; Mark Durst; Chris Vezina; Yu Li


Archive | 2008

Populations d'anticorps homogènes

Tom Dillon; Pavel V. Bondarenko; Martin J. Allen; Alain Balland; Margaret Speed Ricci; Amy Guo; Wenyan Shen; Jeonghoon Sun; Chris Vezina


Archive | 2008

治療用ヒト抗i−il−1r1モノクローナル抗体

Gary Elliott; Haichun Huang; Frank Martin; Brian Varnum; Chris Vezina; Alison Witte; ウィット アリソン; エリオット ギャリー; ベジナ クリス; チャン シェーミン; ファン ハイチュン; バーナム ブライアン; マーティン フランク


Archive | 2003

Therapeutischer monoklonaler anti-il-1r1-antikörper

Haichun Huang; Brian Varnum; Chris Vezina; Alison Witte; Francis H. Martin; Gary Elliott


Archive | 2003

Anticorps monoclonal therapeutique anti-il-1r1 humain

Brian Varnum; Chris Vezina; Alison Witte; Francis H. Martin; Haichun Huang; Gary Elliott

Collaboration


Dive into the Chris Vezina's collaboration.

Researchain Logo
Decentralizing Knowledge